Hos kvinder med intakt uterus stiger risikoen for endometriehyperplasi og endometriecancer med behandlingsvarigheden af østrogen alene.
In women with an intact uterus, the risk of endometrial hyperplasia and endometrial cancer increases with increasing duration of use of unopposed oestrogens.